Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4247378
Max Phase: Preclinical
Molecular Formula: C54H102N18O11
Molecular Weight: 1179.52
Molecule Type: Small molecule
Associated Items:
ID: ALA4247378
Max Phase: Preclinical
Molecular Formula: C54H102N18O11
Molecular Weight: 1179.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C
Standard InChI: InChI=1S/C54H102N18O11/c1-28(2)24-38(64-33(11)73)48(79)69-40(26-30(5)6)50(81)71-41(27-31(7)8)51(82)70-39(25-29(3)4)49(80)67-37(18-15-23-63-54(60)61)47(78)72-43(32(9)10)52(83)68-35(16-12-13-21-55)46(77)66-36(17-14-22-62-53(58)59)45(76)65-34(44(57)75)19-20-42(56)74/h28-32,34-41,43H,12-27,55H2,1-11H3,(H2,56,74)(H2,57,75)(H,64,73)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,79)(H,70,82)(H,71,81)(H,72,78)(H4,58,59,62)(H4,60,61,63)/t34-,35-,36-,37-,38-,39-,40-,41-,43-/m0/s1
Standard InChI Key: DNPNJIIMQSBAFL-NOCWAKEYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1179.52 | Molecular Weight (Monoisotopic): 1178.7975 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):